Serving To Educate Primary Care Clinicians On Metabolic Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
PCMG CME
PCMG Non-CME
Resources
Needs Survey
Commentaries
News
ADA Anemia in CKD Two
I am a(n)…
Select...
MD/DO
NP/RN
PA
Other
How many years have you been in practice?
Select...
1-5
6-10
11-15
16-20
Over 20
What is your practice setting?
Select...
Solo Practice
Group Practice
Hospital
Clinic
Academic
Other
Number of patients seen per month with chronic kidney disease
Select...
1-10
11-20
21-30
31-40
41-50
Over 50
Please rate the following:
Degree to which your educational expectations were met
Select...
Excellent
Above Average
Average
Fair
Poor
Relevance to your practice
Select...
Excellent
Above Average
Average
Fair
Poor
Effective faculty presenter
Select...
Excellent
Above Average
Average
Fair
Poor
Overall Presentation
Select...
Excellent
Above Average
Average
Fair
Poor
Please rate the degree to which the Learning Objective was met.
Implement appropriate treatment for patients with anemia in CKD who can be adequately managed in the primary care setting.
Select...
Completely
Mostly
Somewhat
Not at all
Agree or Disagree?
The presentation was fair and balanced, free of commercial bias.
Select...
YES
NO
I feel more competent as a result of the presentation.
Select...
YES
NO
The presentation was scientifically rigorous.
Select...
YES
NO
The content contributed valuable information that will assist in improving patient outcomes
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
Will you change your practice behaviors as a result of the presentation?
Select...
Absolutely
Probably
Unsure
Unlikely
No
What will you change?
Medications I prescribe
Increased monitoring of patients with anemia in CKD
Screening frequency
Patient education
Colleague education
Know better when to refer
Keep an eye on emerging treatments
Discuss anemia more frequently with patients at risk
Other
If Other
What barriers to change do you foresee?
Cost
Insurance Coverage
Formulary
Patient Compliance
Time with Patient
Other
If Other
What was your level of knowledge on this subject?
Before the presentation
Select...
None
Little
Some
Considerable
Expert
After the presentation
Select...
None
Little
Some
Considerable
Expert
True or False? When treating with an ESA, Hb should be monitored every month during initiation and every other month thereafter.
True
False
ESAs can be initiated if...
Hb <10.0 g/dL
Hb >10.0 g/dL
Hb between 5.0 and 15.0 g/dL
How confident do you feel in your answer to the previous question?
Select...
Very confident
Confident
Somewhat confident
Not confident